Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer

BACKGROUND: Cathepsin-D (CatD), owing to its dual role as a proteolytic enzyme and as a ligand, has been implicated in cancer progression. The role of CatD in pancreatic ductal adenocarcinoma is unknown. METHODS: CatD expression quantified by immunohistochemistry of tumor-tissue microarrays of 403 r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahajan, Ujjwal M, Goni, Elisabetta, Langhoff, Enno, Li, Qi, Costello, Eithne, Greenhalf, William, Kruger, Stephan, Ormanns, Steffen, Halloran, Christopher, Ganeh, Paula, Marron, Manuela, Lämmerhirt, Felix, Zhao, Yue, Beyer, Georg, Weiss, Frank-Ulrich, Sendler, Matthias, Bruns, Christiane J, Kohlmann, Thomas, Kirchner, Thomas, Werner, Jens, D’Haese, Jan G, von Bergwelt-Baildon, Michael, Heinemann, Volker, Neoptolemos, John P, Büchler, Markus W, Belka, Claus, Boeck, Stefan, Lerch, Markus M, Mayerle, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050148/
https://www.ncbi.nlm.nih.gov/pubmed/32296755
http://dx.doi.org/10.1093/jncics/pkz060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050148/
https://www.ncbi.nlm.nih.gov/pubmed/32296755
http://dx.doi.org/10.1093/jncics/pkz060

Ejemplares similares